Pasar al contenido principal

DISFUNCION AUTONOMICA Y RITMO CIRCADIANO EN EL SINDROME DE FATIGA CRONICA/ENCEFALOMIELITIS MIALGICA: NUEVAS HERRAMIENTAS DIAGNOSTICAS Y TERAPEUTICAS EN LA ENFERMEDAD

PI19/00629

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Implications for Long COVID

  • Jurek, Joanna Michalina|||0000-0002-7319-0672
  • Castro-Marrero, Jesús|||0000-0002-2481-3052
Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and long COVID are complex, multisystemic and long-term disabling conditions characterized by debilitating post-exertional malaise and other core symptoms related to immune dysregulation resultant from post-viral infection, including mitochondrial dysfunction, chronic neuroinflammation and gut dysbiosis. The reported associations between altered microbiota composition and cardinal symptoms of ME/CFS and long COVID suggest that the use of microbial preparations, such as probiotics, by restoring the homeostasis of the brain-immune-gut axis, may help in the management of symptoms in both conditions. Therefore, this review aims to investigate the implications of alerted gut microbiome and assess the evidence supporting use of microbial-based preparations, including probiotics, synbiotics, postbiotics alone and/or in combination with other nutraceuticals in the management of fatigue, inflammation and neuropsychiatric and gastrointestinal symptoms among patients with ME/CFS and long COVID.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID

  • Jurek, Joanna Michalina
  • Castro-Marrero, Jesus
Long COVID; Myalgic encephalomyelitis; Probiotics, COVID largo; Encefalomielitis miálgica; Probióticos, COVID llarg; Encefalomielitis miàlgica; Probiòtics, Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and long COVID are complex, multisystemic and long-term disabling conditions characterized by debilitating post-exertional malaise and other core symptoms related to immune dysregulation resultant from post-viral infection, including mitochondrial dysfunction, chronic neuroinflammation and gut dysbiosis. The reported associations between altered microbiota composition and cardinal symptoms of ME/CFS and long COVID suggest that the use of microbial preparations, such as probiotics, by restoring the homeostasis of the brain–immune–gut axis, may help in the management of symptoms in both conditions. Therefore, this review aims to investigate the implications of alerted gut microbiome and assess the evidence supporting use of microbial-based preparations, including probiotics, synbiotics, postbiotics alone and/or in combination with other nutraceuticals in the management of fatigue, inflammation and neuropsychiatric and gastrointestinal symptoms among patients with ME/CFS and long COVID., This research was funded by the National Institute of Health Carlos III (Madrid, Spain) within the framework of the Strategic Action Plan on Health (Grant number: PI19/00629) and co-funded by the European Union (European Regional Development Fund–ERDF 2014-2020): “A way to build Europe”. Vall d’Hebron Research Institute (VHIR) is a member of the CERCA program (Generalitat de Catalunya, Barcelona, Spain).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Skin Temperature Circadian Rhythms and Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, The Role of Endothelin-1 in the Vascular Tone Dysregulation

  • Cambras, Trinitat|||0000-0002-9009-4690
  • Zerón-Rugerio, Maria Fernanda|||0000-0001-5615-7961
  • Díez-Noguera, Antoni|||0000-0002-9613-936X
  • Zaragoza, Maria Cleofé|||0000-0002-9797-0219
  • Domingo, Joan Carles|||0000-0002-6356-0836
  • Sanmartin Sentañes, Ramon|||0000-0002-6415-6368
  • Alegre Martín, José|||0000-0002-7582-7585
  • Castro-Marrero, Jesús|||0000-0002-2481-3052
There is accumulating evidence of autonomic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, little is known about its association with circadian rhythms and endothelial dysfunction. This study aimed to explore the autonomic responses through an orthostatic test and analysis of the peripheral skin temperature variations and vascular endothelium state in ME/CFS patients. Sixty-seven adult female ME/CFS patients and 48 healthy controls were enrolled. Demographic and clinical characteristics were assessed using validated self-reported outcome measures. Postural changes in blood pressure, heart rate, and wrist temperature were recorded during the orthostatic test. Actigraphy during one week was used to determine the 24-h profile of peripheral temperature and activity. Circulating endothelial biomarkers were measured as indicators of endothelial functioning. Results showed that ME/CFS patients presented higher blood pressure and heart rate values than healthy controls in the supine and standing position (p < 0.05 for both), and also a higher amplitude of the activity rhythm (p < 0.01). Circulating levels of endothelin-1 (ET-1) and vascular cell adhesion molecule-1 (VCAM-1) were significantly higher in ME/CFS (p < 0.05). In ME/CFS, ET-1 levels were associated with the stability of the temperature rhythm (p < 0.01), and also with the self-reported questionnaires (p < 0.001). This suggests that ME/CFS patients exhibited modifications in circadian rhythm and hemodynamic measures, which are associated with endothelial biomarkers (ET-1 and VCAM-1). Future investigation in this area is needed to assess dysautonomia and vascular tone abnormalities, which may provide potential therapeutic targets for ME/CFS.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID

  • Jurek, Joanna Michalina
  • Castro-Marrero, Jesus
Long COVID; Myalgic encephalomyelitis; Probiotics, COVID largo; Encefalomielitis miálgica; Probióticos, COVID llarg; Encefalomielitis miàlgica; Probiòtics, Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and long COVID are complex, multisystemic and long-term disabling conditions characterized by debilitating post-exertional malaise and other core symptoms related to immune dysregulation resultant from post-viral infection, including mitochondrial dysfunction, chronic neuroinflammation and gut dysbiosis. The reported associations between altered microbiota composition and cardinal symptoms of ME/CFS and long COVID suggest that the use of microbial preparations, such as probiotics, by restoring the homeostasis of the brain–immune–gut axis, may help in the management of symptoms in both conditions. Therefore, this review aims to investigate the implications of alerted gut microbiome and assess the evidence supporting use of microbial-based preparations, including probiotics, synbiotics, postbiotics alone and/or in combination with other nutraceuticals in the management of fatigue, inflammation and neuropsychiatric and gastrointestinal symptoms among patients with ME/CFS and long COVID., This research was funded by the National Institute of Health Carlos III (Madrid, Spain) within the framework of the Strategic Action Plan on Health (Grant number: PI19/00629) and co-funded by the European Union (European Regional Development Fund–ERDF 2014-2020): “A way to build Europe”. Vall d’Hebron Research Institute (VHIR) is a member of the CERCA program (Generalitat de Catalunya, Barcelona, Spain).